Science & Enterprise subscription

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn

Donate to our blog

Your support will help Science & Enterprise continue to provide science news for business people and business news for scientists.

Targeted Leukemia Drugs Sharply Raising Costs of Care

Drugs directly attacking cancer cell growth show high remission rates with a common form of leukemia, but a new study suggests the high costs of these drugs could impose difficult economic burdens on patients and the health care system. . . . → Read More: Targeted Leukemia Drugs Sharply Raising Costs of Care

Long-Acting Opioid Abuse Therapy Shown Working in Trial

An experimental long-acting drug was shown at least as effective, and in some cases superior, to the current standard of care for opioid use disorder. . . . → Read More: Long-Acting Opioid Abuse Therapy Shown Working in Trial

Florida Voters Give Split Decision on GM Mosquitoes [Updated]

Voters in the Florida Keys yesterday returned a split decision on non-binding ballot questions about testing genetically modified mosquitoes to stop the Zika virus. . . . → Read More: Florida Voters Give Split Decision on GM Mosquitoes [Updated]

Institutes, Companies Form Business to Bridge Discovery Gap

Three research institutions with pharmaceutical and venture capital companies are creating a new enterprise to fill the drug development gap between proof-of-concept and initial clinical trials. . . . → Read More: Institutes, Companies Form Business to Bridge Discovery Gap

FDA Clears Artificial Pancreas System for Type 1 Diabetes

The Food and Drug Administration cleared for sale a system that automatically monitors blood glucose and maintains basic insulin levels in people with type 1 diabetes. . . . → Read More: FDA Clears Artificial Pancreas System for Type 1 Diabetes

Antibiotic Shown to Control Drug-Resistant Gonorrhea

Findings from a clinical trial show a candidate drug kills bacteria causing a type of gonorrhea becoming resistant to current antibiotics. . . . → Read More: Antibiotic Shown to Control Drug-Resistant Gonorrhea

FDA Holding Opioid Overdose App Competition

The U.S. Food and Drug Administration is seeking a smartphone app that can quickly find a source of the antidote drug naloxone for someone having an opioid overdose. . . . → Read More: FDA Holding Opioid Overdose App Competition

Orphan Status Granted for Hemophilia Genome Editing

Treatments using genome-editing techniques for hemophilia B, a rare blood clotting disease, received orphan therapy status from the U.S. Food and Drug Administration. . . . → Read More: Orphan Status Granted for Hemophilia Genome Editing

Takeda Awarded $19.8 Million for Zika Vaccine

Takeda Pharmaceutical Company is receiving $19.8 million from a U.S. public health agency for initial steps to develop a vaccine to prevent Zika infections. . . . → Read More: Takeda Awarded $19.8 Million for Zika Vaccine

FDA Giving Fast-Track Review to Alzheimer’s Candidate

U.S. Food and Drug Administration is giving an accelerated review to a candidate drug designed to treat Alzheimer’s disease by reducing the toxicity of amyloid beta proteins making up the plaque accumulating in the brain. . . . → Read More: FDA Giving Fast-Track Review to Alzheimer’s Candidate